Detailed answers about THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED, including incorporation, status, business activity, and accounts information.
When was THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED founded?
THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED was officially incorporated on 1 October 2021 and is registered under company number 13655339. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED?
THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED do?
THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED's registered address?
The registered office address of THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED is VICE-CHANCELLOR'S OFFICE OXFORD BROOKES UNIVERSITY, HEADINGTON CAMPUS, OXFORD, UNITED KINGDOM, OX3 0BP. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED financially stable?
The most recent accounts for THE GENETICS OF OCULAR DEVELOPMENT NETWORK LIMITED were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 July 2026.